Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients

Author:

Kirchner Johannes,Gerçek Muhammed,Sciacca Vanessa,Reil Jan-Christian,Guckel Denise,Potratz Max,Omran Hazem,Friedrichs Kai,Eitz Thomas,Bleiziffer Sabine,Schramm Rene,Imnadze Guram,Sohns Christian,Gummert Jan,Rudolph Volker,Rudolph Tanja K.,Sommer Philipp,Fink ThomasORCID

Abstract

Abstract Background Permanent pacemaker implantation (PMI) is associated with increased morbidity after transcatheter aortic valve replacement (TAVR). Cardiac resynchronization-therapy (CRT) is recommended for patients if left ventricular ejection fraction (LVEF) is ≤ 40% and ventricular pacing is expected in favor to sole right ventricular (RV) pacing. Meanwhile, LVEF may recover after TAVR in patients with aortic valve disease and the benefit of CRT is unknown. Objective To analyze the impact of CRT implantation as compared to RV pacing after TAVR. Methods and Results Between 2012 and 2022, 4385 patients (53.1% female, mean age 81 ± 6 years) without prior PMI undergoing TAVR were retrospectively identified in our institutional registry. After stratification of patients in LVEF ≤ 40%, 41–49% and ≥ 50%, Kaplan–Meier analysis revealed significantly different survival rates in each subgroup at 5 years (37.0% vs. 43.5% vs. 55.1%; P ≤ 0.021). At multivariate regression, LVEF and new PMI after TAVR were not relevant for survival. A total of 105 patients with LVEF ≤ 40% received PMI after TAVR (86 patients with RV pacing and 19 with CRT). At 5 years, all-cause mortality was significantly lower in patients with CRT-device as compared to patients without CRT-device (Kaplan Meier estimate of 21.1% vs. 48.8%; HR 0.48, CI 0.204 – 1.128; log rank p = 0.045). In multivariate analysis CRT remained a significant factor for 5-year survival in these patients (HR 0.3, CI 0.095–0.951, p = 0.041). Conclusion In patients undergoing TAVR, PMI did not influence 5-year survival. In patients with LVEF ≤ 40%, CRT-device implantation was associated with improved survival compared to non-CRT-device implantation. Graphical Abstract Impact of right ventricular pacing and cardiac resynchronization therapy on patient survival in patients with transcatheter aortic valve replacement. CI = confidence interval, CRT = cardiac resynchronization therapy, HR = hazard ratio, LVEF = left ventricular ejection fraction, RV = right ventricular, TAVR = transcatheter aortic valve replacement

Funder

Ruhr-Universität Bochum

Publisher

Springer Science and Business Media LLC

Reference23 articles.

1. Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, Rodés-Cabau J (2017) Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation 136(11):1049–1069. https://doi.org/10.1161/CIRCULATIONAHA.117.028352

2. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM, Leyva F, Linde C, Abdelhamid M, Aboyans V, Arbelo E, Asteggiano R, Barón-Esquivias G, Bauersachs J, Biffi M, Birgersdotter-Green U, Bongiorni MG, Borger MA, Čelutkienė J, Cikes M, Daubert JC, Drossart I, Ellenbogen K, Elliott PM, Fabritz L, Falk V, Fauchier L, Fernández-Avilés F, Foldager D, Gadler F, De Vinuesa PGG, Gorenek B, Guerra JM, Hermann Haugaa K, Hendriks J, Kahan T, Katus HA, Konradi A, Koskinas KC, Law H, Lewis BS, Linker NJ, Løchen ML, Lumens J, Mascherbauer J, Mullens W, Nagy KV, Prescott E, Raatikainen P, Rakisheva A, Reichlin T, Ricci RP, Shlyakhto E, Sitges M, Sousa-Uva M, Sutton R, Suwalski P, Svendsen JH, Touyz RM, Van Gelder IC, Vernooy K, Waltenberger J, Whinnett Z, Witte KK (2022) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace 24(1):71–164. https://doi.org/10.1093/europace/euab232. (Erratum in: Europace. 2022 Mar 07)

3. van Rosendael PJ, Delgado V, Bax JJ (2018) Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J 39(21):2003–2013. https://doi.org/10.1093/eurheartj/ehx785

4. Fujita B, Schmidt T, Bleiziffer S, Bauer T, Beckmann A, Bekeredjian R, Möllmann H, Walther T, Landwehr S, Hamm C, Beyersdorf F, Katus HA, Harringer W, Ensminger S, Frerker C, GARY Executive Board (2020) Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. Eur J Cardiothorac Surg. 57(1):151–159. https://doi.org/10.1093/ejcts/ezz168

5. Fadahunsi OO, Olowoyeye A, Ukaigwe A, Li Z, Vora AN, Vemulapalli S, Elgin E, Donato A (2016) Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. society of thoracic surgeons/American college of cardiology TVT registry. JACC Cardiovasc Interv. 9(21):2189–2199. https://doi.org/10.1016/j.jcin.2016.07.026

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3